Vertex Pharmaceuticals Inc. buy Jefferies Financial Group Inc.
Start price
09.12.24
/
50%
€440.25
Target price
09.12.25
€519.86
Performance (%)
-15.62%
End price
10.12.25
€371.50
Summary
This prediction ended on 10.12.25 with a price of €371.50. The prediction for Vertex Pharmaceuticals Inc. disappointed with a performance of -15.62%. Jefferies_Financial_ has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.465% | -1.465% | 3.555% |
| iShares Core DAX® | 2.591% | 2.467% | 8.839% |
| iShares Nasdaq 100 | -0.915% | -6.458% | 24.933% |
| iShares Nikkei 225® | 0.145% | -8.773% | 47.385% |
| iShares S&P 500 | -0.367% | -1.220% | 21.667% |
Comments by Jefferies_Financial_ for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $550.00 price target on the stock, up previously from $500.00.
Ratings data for VRTX provided by MarketBeat
Current prediction by Jefferies_Financial_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€426.65
10.03.26
10.03.26
€498.92
10.03.27
10.03.27
-3.05%
31.07.26
31.07.26
